Risk for Parkinson's disease among patients with osteoarthritis: A Danish cohort study

Movement Disorders

Volumn 25, Issue 14, 2010, Pages 2355-2360

  Rugbjerg, Kathrine ^a   Friis, Søren ^a,b   Jørgensen, Thomas L ^a   Ritz, Beate ^c   Korbo, Lise ^d   Olsen, Jørgen H ^a  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Anti inflammatory drugs; Osteoarthritis; Parkinson's disease

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HIP SURGERY; HUMAN; KNEE SURGERY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING HABIT;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; COHORT STUDIES; DENMARK; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OSTEOARTHRITIS; PARKINSON DISEASE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77958575827     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23274     Document Type: Article

References (30)

1. Koller W, O'Hara R, Weiner W, et al. Relationship of aging to Parkinson's disease. Adv Neurol 1987; 45: 317-321.
2. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-39.
3. Pfeiffer RF. Non-motor parkinsonism. Parkinsonism Relat Disord 2007; 13: S211-S220.
4. Gasser T. Update on the genetics of Parkinson's disease. Mov Disord 2007; 14: S343-S350.
5. Chen H, Zhang SM, Hernan MA, et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol 2003; 60: 1059-1064.
6. Chen H, Jacobs E, Schwarzschild MA, et al. Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann Neurol 2005; 58: 963-967.
7. Samii A, Etminan M, Wiens MO, Jafari S. NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies. Drugs Aging 2009; 26: 769-779.
8. Wahner AD, Bronstein JM, Bordelon YM, Ritz B. Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease. Neurology 2007; 69: 1836-1842.
9. Rugbjerg K, Friis S, Ritz B, et al. Autoimmune disease and risk for Parkinson disease. A population-based case-control study. Neurology 2009; 73: 1462-1468.
10. Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-268.
11. Danish Board of Health. Danish classification of surgical procedures and therapies, 1st, 2nd, 3rd, and 4th eds. Denmark: Danish Board of Health; 1973, 1980, 1988, and1995.
12. NOMESCO. Classification of external causes of injuries, 1st and 2nd eds. Copenhagen, Denamrk: NOMESCO; 2007.
13. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997; 44: 535-539.
14. Cuzick J, Otto F, Baron JA, et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 2009; 10: 501-507.
15. Elwood PC, Gallagher AM, Duthie GG, et al. Aspirin, salicylates, and cancer. Lancet 2009; 373: 1301-1309.
16. Bailar JC, Ederer F. Significance factors for the ratio of a Poisson variable to its expectation. Biometrics 1964; 20: 639-643.
17. WHO.ATC/DDD Classification, WHO Drug Information, Vol. 15. Geneva: World Health Organization 2001. p 84-88.
18. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997; 44: 445-448.
19. Sorensen HT, Friis S, Norgard B, et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 2003; 88: 1687-1692.
20. Danish Medical Agency. 2009.
21. Friis S, Sorensen HT, McLaughlin JK, et al. A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer 2003; 88: 684-688.
22. Friis S, Poulsen AH, Sorensen HT, et al. Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study. Cancer Causes Control 2009; 20: 731-740.
23. Hernan MA, Logroscino G, Garcia Rodriguez LA. Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease. Neurology 2006; 66: 1097-1099.
24. Ton TG, Heckbert SR, Longstreth WTJr, et al. Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease. Mov Disord 2006; 21: 964-969.
25. Etminan M, Carleton BC, Samii A. Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study. J Clin Neurosci 2008; 15: 576-577.
26. Rugbjerg K, Ritz B, Korbo L, et al. Risk of Parkinson's disease after hospital contact for head injury: population based case-control study. BMJ 2008; 337: a2494.
27. Olsen JH, Friis S, Poulsen AH, et al. Use of NSAIDs, smoking and lung cancer risk. Br J Cancer 2008; 98: 232-237.
28. Elloumi M, Kallel MH. Which relationship does osteoarthritis share with smoking? Osteoarthritis Cartilage 2007; 15: 1097-1098.
29. Gullahorn L, Lippiello L, Karpman R. Smoking and osteoarthritis: differential effect of nicotine on human chondrocyte glycosaminoglycan and collagen synthesis. Osteoarthritis Cartilage 2005; 13: 942-943.
30. Thacker EL, O'Reilly EJ, Weisskopf MG, et al. Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology 2007; 68: 764-768.